Craig Donohue
Analyst · Keith, Bruyette and Woods
Thank you, John, and thank you for joining us this morning. I'll be discussing our performance in the third quarter and providing updates on a few of our strategic initiatives before turning things over to Jamie to review the financials. CME posted solid third quarter results with average daily volume up 14% from the same period last year. Net income of 21% to $244 million and earnings per share of $3.66, up 20%. The foundation of our performance lies in our product diversity. Energy and metals contribute 32% of transaction fee revenues; interest rates, 27%; equities, 21%; and foreign exchange and commodity products contribute the remainder. The breadth and diversity of our product line is beneficial when we face macro economic headwinds, in particular, market segment. Importantly, I'll note that though we've seen volume performance within the individual asset classes varies throughout the year, we have continued to see open interest build from quarter-to-quarter in everyone of our product lines. Open interest currently sits at 92.4 million contracts, up 12% compared to the same period last year and just below the all-time record of 95 million. To review some of our volume statistics, third quarter average daily volume was up 14% versus the same period last year and was down 15% versus the second quarter of this year, due to extraordinary performance in Q2 and the typical impacts of seasonality during July and August. Turning to interest rates. Diminished activity in short-term rates was significantly offset by strong growth in our Treasury products, as I will describe in a moment. Average daily Eurodollar volume was down 7%, however, longer dated Eurodollar contracts with expirations beyond September 2012 saw record average daily volume of 320,000 contracts, up 32% from the prior year as there continues to be more volatility at the long end of the curve. Eurodollar mix curve options, which are short-dated expirations on longer-dated futures contracts, have also experienced impressive volume growth this quarter from approximately 6,000 average daily volume last year to 87,000 this quarter and with open interest growing from 330,000 contracts to 1.2 million contracts today at quarter end. Importantly, Eurodollar opened interest across the whole yield curve continues to grow including in the first two years. While short-term interest rates continued to be affected by monetary policy, it is important to recognize that Eurodollar products represent only 12% of total transaction fees at CME Group. As I mentioned, Treasury products had a very strong third quarter with average daily volumes up 38% in futures and with options volumes up 62%. As we've seen expectations for interest rate increases move out on the curve, products at the longer end of the curve are seeing greater activity. An additional positive to the strong Treasury volume is that the Treasury's weight for contract is generally higher than that Eurodollar RPC. We continue also to successfully innovate new products and product extensions that meet customers needs and enhance our performance in this segment of our business. We've had tremendous success with our Ultra Long Bond Treasury features, which posted average daily volumes of 33,000 contracts in Q3 and open interest of 222,000 contracts. Just this week, we also launched our on-the-run Treasury futures contracts, which our customers are very excited about. The robust liquidity and diversed customer base in our core Treasury products enabled us to effectively develop these product extensions, which in turn allows us to provide our customers with more trading opportunities at CME Group. In other product areas, average daily volume in our equity products was up 6% for the quarter, outperforming cash equity market volumes and reflecting asset allocation preferences and the outflow of funds from equities to fixed income market throughout 2010. Average daily volume in our FX products was up 31% over third quarter last year and open interest trends remained positive with current levels at a near record of $1.6 million. Growth in CME FX is coming from diversed sources. We saw 40% volume growth in the Australian and Canadian dollar markets, which historically had been less actively traded currency pairs at CME. Additionally, FX activity was up 54% during non-U.S. trading hours and this asset class continues to be our fastest growing segment during non-U.S. hours. FX options also continued to perform extremely well with average daily volume up 182% over third quarter 2009 and open interest growth of 101% versus the same period a year ago. Finally, another positive indicator for our FX business came out of the recently released BIS tri-annual survey, which shows that the global FX market grew 20% from April 2007 to April 2010, while CME FX volume grew 94% in that same period, clearly demonstrating the increasing importance of our products to the global FX marketplace. The BIS survey also indicated that global FX options declined 2%, while CME FX option volumes grew 250%. We believe there are three factors driving this out performance. First, CME central counter-party clearing, which enables wider participation by a diversed set of buy-side customers. Second, our significantly expanding liquidity across a broad range of CME currency pairs as our FX markets have indeed become a major source of liquidity in global FX market. And third, electronic access to both futures and options on our CME Globex electronic trading platform. Together, these factors should continue to drive growth in our FX business. To round out our other asset classes, our agricultural commodity, energy and metals products have all shown outstanding growth year-to-date and also are on track for a strong fourth quarter. These products tend to earn our highest rates per contract but growth here is very accretive. Agricultural commodities had a strong quarter with volumes up 33% versus last year, led by outstanding growth in corn and wheat volumes of 56% and 72% respectively. Energy was up 12% to 1.7 million contracts per day, our second highest quarterly volume and energy open interest remains at near record levels. Finally, metals average daily volume was up 28%. I'd also like to touch on continued growth in international volumes in our core product lines. During the third quarter, we saw strong growth of 37% in Globex volumes during non-U.S. hours. Volume from our various international hubs also grew 15% compared to the same quarter a year ago and now represents 15% of overall Globex volume. We continued to focus on globalization of our core business as we expect growth in emerging markets to outpace growth in more developed markets. One example of our commitment to achieving growth from globalization is our recently announced enhancements to our global client development and sales organization. Our new structure will better enable us to cross sell all CME Group products and services to our global customers, while also allowing us to better understand and meet the needs of our largest customer segments including banks, intermediaries, asset managers, hedge funds, proprietary trading firms and of course commercial participant. The new structure has been designed to better target cross asset sales across client segments to drive international growth, specifically in Asia and Europe, and to generate new client participation across all regions. The ultimate goal is to more effectively serve our clients and enhance our global sales and marketing efforts for the entire suite of CME Group products. During the quarter, we hired a new head of Global Client Development and Sales, Alice Hacket, former Managing Director and Co-Head of Global Prime Finance at Citigroup. Alice joins us and will oversee our worldwide clients development and sales efforts. Moving on to our strategic initiatives, we were very pleased to extend our OTC clearing services into interest rate on October 18. This offering provides the extensive counter party, risk reduction and transparency of CME clearing while preserving the prevailing execution processes, technology platform and economic structures used in the bilateral IRS market today. As the Clearing Only provider in this space, we are execution-agnostic and offer operational flexibility to our customers by accepting trades from a variety of venues. Finally, as we continue to build our OTC offerings and other asset classes, CME Group has a significant lead in providing a comprehensive multi-asset class clearing solutions to the market for the maximum operational ease and capital efficiency that comes with connecting to a single clearing house. To date, we've cleared $660 million in interest rates swaps and have $648 million in open interest, with participation across a wide variety of firms. We see this effort as being in the very early stages and recognize that many clients are waiting for greater clarity on final rules before moving forward with cleared interest rate swaps. Currently, we're focused on delivering key additions to the offering in order to make it possible for more users to access our services. Some of the details we are working towards include receiving approval for a structure to allow cross margining with exchange-traded futures and options and finalizing regulatory approvals allowing certain types of neutral funds post collateral. We are also working on expanding the product scope to offer more product flexibility and swaps denominated in additional currencies. I'd also like to share an update on the development of our co-location services offering for all CME Group customers. Our offering will allow customers to co-locate their servers in CME Group's new state-of-the-art data center. Co-location will create the lowest possible latency hosting environment for our customers. The offering is available to all customers and all customers will be treated equally with transparent and market-based pricing. Equidistant access points will also ensure fair and equal access. The uptake during our initial application period has been positive, and we are in the process of allocating space to our customers. Once customers' base for this space is allocated, we will begin to built out the facilities and are planning for an early 2012 go-live date. Based on current indications of interest from our customers, we expect this service to add approximately $30 million to $40 million in revenue in 2012 and to further scale from there. Finally, I'd like to offer a brief regulatory update. We are participating actively in the Dod-Frank will-making processes being undertaken by the CFTC and other financial and markets regulators. Our team is working with them and our customers to ensure that new regulations create a fair and level playing field for all market participants and that U.S. markets are not disadvantaged compared to other global markets centers. The CFTC and other regulators will be issuing a real proposal in many areas over the next few months. Like many of you, we are already engaging in the public comment process and anticipate a robust and healthy dialogue about the many issues that regulators are addressing. We will continue to keep you posted on these critical topics as they develop. In conclusion, CME Group continues to be successful in managing our core business and executing on our strategies to further global our entire business and expand our capabilities into OTC market. While the macroeconomic climate has been challenging for everyone, our performance over the past two years has proven that we can leverage our diverse product set to deliver results in a variety of cyclical and economic environment. With that, I'd like to turn the call over to Jamie.